Novartis acquires option to acquire Zurich-based startup Cellerys
Novartis has signed a collaboration agreement and an option to acquire Cellerys. The Zurich-based startup is researching an innovative therapy to combat multiple sclerosis (MS).
Swiss Nuclides raises CHF 2.6m in Series A Financing
Swiss Nuclides AG, a developer of novel radionuclide PET tracers for the precision diagnostics, has raised CHF 2.6m.
DomoSafety SA closes a Serie B financing round
DomoSafety SA, a leading company in the digital health segment, announced the successful closing of its Series B financing round.
Faveeo SA closes a Series B financing round
Faveeo SA, a Swiss start-up, announced the successful closing of its Series B financing round.
Haya Therapeutics completes CHF 18m Seed Financing Round
HAYA Therapeutics SA announced the successful closing of its CHF 18m seed round.
Oculis closes an oversubscribed USD 57m Series C financing round
Oculis S.A., a late-stage biopharmaceutical company, focused on developing transformative ophthalmic treatments to improve the sight and lives of patients, has closed an oversubscribed USD 57m Series C financing round.
First closing of EUR 130m by MTIP
Basel-based MTIP, a private equity firm focusing on digital health and connected medical device companies, has completed a first closing of EUR 130m...
Majority stake of STIMIT sold to Dräger
The Swiss-based start-up medical technology company STIMIT AG was founded in 2018...
CITIC becomes largest shareholder in MedAlliance
Trustar Capital (formerly known as CITIC Capital Partners), a private equity affiliate of CITIC Capital Holdings Limited, has completed its over USD 50.0m investment in the Switzerland based global leading medical technology company MedAlliance SA ("MedAlliance"), becoming MedAlliance's single largest shareholder.
exceet Card Group acquires Intercard
exceet Card Group, a leading European provider of smart card solutions, acquired Intercard Holding AG, a leading Swiss provider of smart card solutions.